A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer
Clinical trial NCT02262741 · COMPLETED
Trial details
- NCT number
- NCT02262741
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-15
- Primary completion
- 2017-09-21
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.